Shandong Hi-tech Spring Material Technology Valuation
Is 301292 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 301292 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 301292's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 301292's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 301292?
Other financial metrics that can be useful for relative valuation.
What is 301292's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥3.28b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.3x |
Enterprise Value/EBITDA | 22.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 301292's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.8x | ||
603110 New East New Materials | 8x | n/a | CN¥3.2b |
603601 Chongqing Zaisheng Technology | 2.1x | 14.4% | CN¥3.4b |
688179 Shanghai Aladdin Biochemical TechnologyLtd | 7.9x | 23.6% | CN¥3.3b |
300715 Jiangsu Canlon Building Materials | 1.2x | 18.7% | CN¥3.3b |
301292 Shandong Hi-tech Spring Material Technology | 1x | 8.2% | CN¥3.3b |
Price-To-Sales vs Peers: 301292 is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (4.8x).
Price to Earnings Ratio vs Industry
How does 301292's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Sales vs Industry: 301292 is good value based on its Price-To-Sales Ratio (1x) compared to the CN Chemicals industry average (2.2x).
Price to Sales Ratio vs Fair Ratio
What is 301292's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1x |
Fair PS Ratio | 0.7x |
Price-To-Sales vs Fair Ratio: 301292 is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.